Omixon - HLA Genomics & NGS Partner

Company Overview:
Omixon is a molecular diagnostics company dedicated to transitioning the HLA (Human Leukocyte Antigen) community to Next Generation Sequencing technologies. The company specializes in high-resolution HLA genotyping, providing advanced bioinformatics solutions for genomics researchers and clinical laboratories. Omixon's expertise in HLA typing combines cutting-edge NGS technology with sophisticated software for accurate, high-resolution genetic profiling.

Product Specialties & Applications:
Omixon's primary offerings include NanoTYPE HLA for high-resolution HLA genotyping using Oxford Nanopore long-read sequencing technology; Holotype HLA workflow for comprehensive HLA profiling; and HLA Twin software for advanced data analysis and interpretation. The company provides advanced bioinformatics training and support for genomics researchers, including onsite training, reference lab training, and remote consultation services. Their solutions are designed for seamless implementation in histocompatibility and immunogenetics laboratories.

Alignment with Mega Life Science:
Omixon's specialized HLA genomics solutions enhance Mega Life Science's product range for immunogenetics and transplant diagnostics. By distributing Omixon's NanoTYPE HLA and advanced bioinformatics tools, Mega Life Science offers customers high-resolution HLA genotyping capabilities for transplant immunology, disease association studies, and population genetics research. This partnership expands Mega Life Science's portfolio with specialized NGS-based HLA typing solutions.

Website: https://www.omixon.com/